Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Total Current Liabilities: 2020-2023

Historic Total Current Liabilities for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $7.8 million.

  • Immuneering's Total Current Liabilities rose 23.08% to $6.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $6.9 million, marking a year-over-year increase of 23.08%. This contributed to the annual value of $7.8 million for FY2023, which is 2.59% down from last year.
  • As of FY2023, Immuneering's Total Current Liabilities stood at $7.8 million, which was down 2.59% from $8.1 million recorded in FY2022.
  • In the past 5 years, Immuneering's Total Current Liabilities registered a high of $8.1 million during FY2022, and its lowest value of $2.3 million during FY2020.
  • In the last 3 years, Immuneering's Total Current Liabilities had a median value of $7.8 million in 2023 and averaged $7.2 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first surged by 149.74% in 2021, then dropped by 2.59% in 2023.
  • Immuneering's Total Current Liabilities (Yearly) stood at $2.3 million in 2020, then skyrocketed by 149.74% to $5.6 million in 2021, then skyrocketed by 42.96% to $8.1 million in 2022, then decreased by 2.59% to $7.8 million in 2023.